Wells Fargo Advisors is setting up a newly designed RIA Solutions channel seeded by advisors from its broker/dealer FiNet, ...

OKLAHOMA CITY, OK, UNITED STATES, January 12, 2026 /EINPresswire.com/ -- INSURICA Insurance Services, LLC announced ...

The combination of greater accessibility, better education and highly unpredictable markets makes options an essential part ...

note inc. ( (JP:5243)) has shared an announcement. note inc. has finalized the terms for issuing stock acquisition rights as stock options to its employees, following a board resolution passed on ...

COLUMBUS, Ohio (WCMH) — For months, NBC4 Investigates has been digging into concerns from Central Ohio families who say the dream of homeownership has turned into years of uncertainty. They’re part of ...

Students and adults with disabilities enrolled in the Delaware County Intermediate Unit’s Options program helped make the holiday season brighter by providing free gift wrapping to DCIU employees on ...

The U.S. Department of Education plans to end a student loan debt forgiveness program used by millions of Americans. The feds said Dec. 9 that they had reached a proposed court settlement to kill the ...

Seeking Alpha's roundup of statements, announcements, and remarks that could impact markets, sectors, or individual stocks. Treasury Secretary Scott Bessent said the Trump administration would be able ...

However, the Ole Miss head coach will only be coaching one team next season. Kiffin is expected to reveal his plans for 2026 on Saturday, one day following the "Egg Bowl' between the Rebels and ...

Moderna ( (MRNA)) has provided an update. On November 12, 2025, Moderna, Inc. held a Special Meeting of Shareholders where two proposals were approved. The first was a one-time stock option exchange ...

COLUMBUS, Ohio (WCMH) — After NBC4 Investigates’ story aired Thursday night, one more local family is a step closer to buying their home. NBC4 Investigates, Isabel Cleary, showed how dozens of area ...

Incyte (INCY) has signed an agreement with Prelude Therapeutics (PRLD) for an exclusive option license for Prelude's mutant selective JAK2V617F JH2 inhibitor program to treat a type of rare blood ...